Anuh Pharma Balance Sheet Health
Financial Health criteria checks 6/6
Anuh Pharma has a total shareholder equity of ₹3.0B and total debt of ₹135.7M, which brings its debt-to-equity ratio to 4.5%. Its total assets and total liabilities are ₹4.3B and ₹1.3B respectively. Anuh Pharma's EBIT is ₹627.4M making its interest coverage ratio -87.1. It has cash and short-term investments of ₹519.2M.
Key information
4.5%
Debt to equity ratio
₹135.67m
Debt
| Interest coverage ratio | -87.1x |
| Cash | ₹519.21m |
| Equity | ₹3.03b |
| Total liabilities | ₹1.31b |
| Total assets | ₹4.34b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 506260's short term assets (₹3.1B) exceed its short term liabilities (₹1.3B).
Long Term Liabilities: 506260's short term assets (₹3.1B) exceed its long term liabilities (₹17.4M).
Debt to Equity History and Analysis
Debt Level: 506260 has more cash than its total debt.
Reducing Debt: 506260's debt to equity ratio has reduced from 6.3% to 4.5% over the past 5 years.
Debt Coverage: 506260's debt is well covered by operating cash flow (74.7%).
Interest Coverage: 506260 earns more interest than it pays, so coverage of interest payments is not a concern.